Bruno Mller - Koninklijke DSM Head Products

Insider

Bruno Mller is Head Products of Koninklijke DSM NV
Age 66
Phone31 45 578 8111
Webhttps://www.dsm.com

Koninklijke DSM Management Efficiency

The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.
Koninklijke DSM NV has accumulated 2.84 B in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Koninklijke DSM NV has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Koninklijke DSM until it has trouble settling it off, either with new capital or with free cash flow. So, Koninklijke DSM's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Koninklijke DSM NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Koninklijke to invest in growth at high rates of return. When we think about Koninklijke DSM's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Matt GloverNetSol Technologies
N/A
Emily PicarelloNRG Energy
40
Carlos RuisanchezSouthwest Gas Holdings
49
Emily CPANRG Energy
43
Tami CaseyQualys Inc
N/A
Alexander CFADatadog
N/A
David ObstlerDatadog
64
E ConleySouthwest Gas Holdings
63
Adam BlitzerDatadog
43
Maddie WagnerKinetik Holdings
N/A
Joo KimQualys Inc
N/A
Nicolas ChaillanQualys Inc
40
Suresh BalasubramanianQualys Inc
N/A
Ishpreet SinghQualys Inc
N/A
Anne PsencikKinetik Holdings
61
Alexis LeQuocDatadog
49
JeanneMey SunNRG Energy
N/A
Alexandra PrunerNRG Energy
59
Salim GhauriNetSol Technologies
68
Antonio CarrilloNRG Energy
54
A ThomanSouthwest Gas Holdings
69
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. Royal D operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people. Koninklijke DSM NV [RDSMY] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Koninklijke DSM NV Leadership Team

Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Wolters, Head Chemicals
Bruno Mller, Head Products
Paul Gilgen, Head Products
Manfred Eggersdorfer, VP Advocacy
Lieke JongTops, Communications Mang
Geraldine Matchett, CFO and Member of the Managing Board
Luca Rosetto, VP Products
Dimitri Vreeze, Member of the Managing Board
Dave Huizing, Vice President Investor Relations
Rob Atsma, Head Nederland

Koninklijke Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Koninklijke OTC Stock

If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets